NYSE · Unclassified100% Authentic Upstream Feed (MR-007)

Bristol-Myers Squibb Co (BMY)

Real-time institutional stock price, dual quantitative model evaluation (4-Factor Quant Rank + 6-Factor Fundamental Composite), valuation multiples, and forensic accounting audit.

Live Authentic Market Price
$62.28
$-0.50 (-0.80%)
Vol: 2,730,000
Market Capitalization$127.26B
P/E Multiple (TTM)13.80
52-Week Range$45.26 – $68.64
Beta / Volatility0.20
Model A · Equal-Weight 25%

4-Factor Quant Rank

#163
Percentile Score:72.7 / 100
Valuation Percentile:90.5
Growth Percentile:55.9
Business Quality Percentile:82.4
Momentum Percentile:62.1
Cross-sectional universe comparison across 2,714 U.S. equities (Official v2.1).
Model B · Fundamental Pillars

6-Factor Fundamental Rating

A+
Fundamental Score:Partial
86/100
Valuation:A+
Growth:A
Profitability:A+
Financial Health:—
EPS Revisions:—
Dividend Quality:B+
Absolute balance sheet health and SEC Edgar filing verification.

Source-Backed Financial Highlights

SEC EDGAR & Market Data Lineage
Revenue (TTM)$48.19B
Diluted EPS$4.51
Forward P/E9.29
Price to Sales—
Operating Margin3237.0%
Net Margin1847.0%